DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $400,149 | +0.9% | 28,623 | +6.6% | 0.01% | -13.3% |
| Q3 2023 | $396,456 | +40.6% | 26,842 | +19.7% | 0.02% | +25.0% |
| Q2 2022 | $282,000 | +16.0% | 22,418 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $243,000 | -22.9% | 22,418 | 0.0% | 0.01% | -20.0% |
| Q4 2021 | $315,000 | -21.4% | 22,418 | +7.4% | 0.01% | -28.6% |
| Q3 2021 | $401,000 | +125.3% | 20,879 | +15.8% | 0.01% | +133.3% |
| Q2 2021 | $178,000 | +0.6% | 18,031 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $177,000 | +101.1% | 18,031 | -9.3% | 0.01% | +75.0% |
| Q4 2020 | $88,000 | +2.3% | 19,887 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $86,000 | – | 19,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |